Profil bibliographique

Robert McEwen

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

8Publications signalées

1Citations signalées

0Affiliations récentes

Les domaines associés

HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchRadiomics and Machine Learning in Medical ImagingRadiopharmaceutical Chemistry and ApplicationsColorectal Cancer Treatments and Studies

Les publications récentes

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Data 1 from Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors

Vicky Makker, Jung‐Yun Lee, Do‐Youn Oh, Ana Oaknin et autres

0 citations

Accès ouvert 2026 other OpenAlex

Table 1 from Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors

Vicky Makker, Jung‐Yun Lee, Do‐Youn Oh, Ana Oaknin et autres

0 citations

Accès ouvert 2026 other OpenAlex

Data from Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors

Vicky Makker, Jung‐Yun Lee, Do‐Youn Oh, Ana Oaknin et autres

1 citation

Accès ouvert 2026 other OpenAlex

Table 3 from Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors

Vicky Makker, Jung‐Yun Lee, Do‐Youn Oh, Ana Oaknin et autres

0 citations

Accès ouvert 2026 other OpenAlex

Table 5 from Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors

Vicky Makker, Jung‐Yun Lee, Do‐Youn Oh, Ana Oaknin et autres

0 citations

Accès ouvert 2026 other OpenAlex

Table 4 from Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors

Vicky Makker, Jung‐Yun Lee, Do‐Youn Oh, Ana Oaknin et autres

0 citations

Accès ouvert 2026 other OpenAlex

Table 2 from Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors

Vicky Makker, Jung‐Yun Lee, Do‐Youn Oh, Ana Oaknin et autres

0 citations

Accès ouvert 2026 other OpenAlex

Figure 1 from Post Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid Tumors

Vicky Makker, Jung‐Yun Lee, Do‐Youn Oh, Ana Oaknin et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.